Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QMF Twisthaler versus placebo and active comparator in persistent asthma
2007-003192-39Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of indacaterol + mometasone furoate in asthma and persistent asthma (3 arms), sponsored by Novartis. Primary endpoint: Change from period baseline FEV1 to 24-hour post-dose trough FEV1. Started Aug 2007; status: completed.
02
Drugs
indacaterol + mometasone furoate
03
Conditions
asthmapersistent asthma
Beyond the preview
Go deeper on 2007-003192-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003192-39.